January 16, 2026 – Talk Bio

Actionable Insights Powered by AI

J&J Reports Positive Phase 3 MajesTEC-9 Results for Tecvayli in Earlier Multiple Myeloma

6 hours ago talkbio0Tagged J&J, Multiple Myeloma, Oral region, PFS, Phase 3, TECVAYLI

Tecvayli; J&J; Phase 3; MajesTEC-9; multiple myeloma; PFS; OS

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

19 hours ago talkbio0Tagged ADCs, AnTenGager, Antengene, ATG-022, ATG-125, ATG-207, Conferences, JPM, TCEs

Antengene; JPM Conference; ATG-022; ADCs; TCEs; AnTenGager; ATG-125; ATG-207

FDA Delays Reviews for Eli Lilly, Sanofi, and Others in New Priority Voucher Program Due to Safety and Efficacy Concerns

19 hours ago talkbio0Tagged concerns, delays, Effectiveness, eli lilly, issues, orforglipron, Safety, sanofi, Tzield, United States Food and Drug Administration, voucher program

FDA delays; Eli Lilly; Sanofi; voucher program; orforglipron; Tzield; safety concerns; efficacy issues